Портальная гипертензионная гастропатия: возможности улучшения результатов лечения кровотечений
А. А. Щеголев, О А Аль Сабунчи, A. Yu. Chevokin et al. · Лечебное дело · 2015
The study was aimed to improve the treatment of patients with bleeding caused by portal hypertensive gastropathy. The study included 94 patients with cirrhosis and portal hypertension after gastrointestinal bleeding. To prevent rebleeding in the first group (n = 56) endoscopic argon-plasma coagulation was performed and octreotide was administered. In the second group (n = 38) only argon-plasma coagulation was used. In the first group there were no rebleeding episodes and deaths, while in the second group rebleeding was noted in three patients (7.9%).
Cited by 0 works.